How to Buy themismed Shares on Fincept?
You can buy Themis Medicare Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: Themis Medicare Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Themismed, including updates on board meetings and corporate actions.
Themis Medicare Limited - https://www.themismedicare.com
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. The company offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics. It also offers anti-inflammatory drugs and other drugs. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1952 and is headquartered in Mumbai, India.
Themis Medicare Limited Share Price Today
225.00
OPEN
230.45
HIGH
222.40
LOW
223.80
CLOSE
80 K
VOLUME
2,446 Cr
Market Cap
251760
Average Volume
Healthcare
Sector
NSI
Exchange
Themis Medicare Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: THEMISMED Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Themis Medicare Limited |
THEMISMED |
INE083B01016 |
Annual General Meeting/Dividend - Rs 0.50 Per Share |
12 Jul 2024 |
1 |
N/A |
Themis Medicare Limited |
THEMISMED |
INE083B01016 |
Face Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per Share |
10 Oct 2023 |
1 |
N/A |
Themis Medicare Limited |
THEMISMED |
INE083B01016 |
Annual General Meeting/Dividend - Rs 5 Per Share |
01 Sep 2023 |
1 |
N/A |
Themis Medicare Limited |
THEMISMED |
INE083B01016 |
Annual General Meeting/Dividend - Rs 5 Per Share |
08 Sep 2022 |
1 |
N/A |
Themis Medicare Limited |
THEMISMED |
INE083B01016 |
Annual General Meeting/Dividend - Rs 4.30 Per Share |
08 Sep 2021 |
1 |
N/A |
NSE: THEMISMED Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
THEMISMED |
02 Jan 2025, 17:30:01 |
General Updates |
Pharmaceuticals |
THEMISMED |
26 Dec 2024, 18:16:25 |
Trading Window-XBRL |
Pharmaceuticals |
THEMISMED |
26 Dec 2024, 18:06:56 |
Trading Window |
Pharmaceuticals |
THEMISMED |
19 Nov 2024, 20:38:28 |
Delay/default in the payment of fines/penalties/dues etc. to authority |
Pharmaceuticals |
THEMISMED |
19 Nov 2024, 16:56:30 |
Spurt in Volume |
Pharmaceuticals |
NSE: THEMISMED Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Themis Medicare Limited |
THEMISMED |
17 Oct 2024, 19:01:00 |
17 Oct 2024, 19:02:00 |
|
Themis Medicare Limited |
THEMISMED |
07 Nov 2024, 19:00:00 |
07 Nov 2024, 19:00:00 |
|
Themis Medicare Limited |
THEMISMED |
19 Jul 2024, 18:24:00 |
19 Jul 2024, 18:24:00 |
|
Themis Medicare Limited |
THEMISMED |
19 Apr 2024, 16:38:00 |
19 Apr 2024, 17:00:00 |
|
Themis Medicare Limited |
THEMISMED |
19 Jan 2024, 10:00:00 |
19 Jan 2024, 10:30:00 |
NSE: THEMISMED Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Chairperson & Executive Director |
02 Nov 1948 |
29 Jun 2007 |
00033273 |
Dinesh S Patel |
Active |
Independent Director |
02 Feb 1959 |
10 Feb 2014 |
00162200 |
Hariharan Subramaniam |
Active |
Non-Executive Director |
05 Mar 1954 |
27 Apr 2007 |
00134856 |
Rajneesh Kedarnath Anand |
Active |
Executive Director |
18 Jan 1975 |
29 Jun 2007 |
00033353 |
Sachin Dinesh Patel |
Active |
Independent Director |
09 Jun 1965 |
11 Nov 2020 |
00330363 |
Manjul Sandhu |
Active |
NSE: THEMISMED Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
THEMIS MEDICARE LIMITED has informed the Exchange about Board Meeting to be held on 25-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 . |
THEMISMED |
N/A |
INE083B01016 |
Themis Medicare Limited |
18 Oct 2024, 23:04:36 |
Financial Results |
THEMISMED |
N/A |
INE083B01016 |
Themis Medicare Limited |
16 Jul 2024, 19:24:19 |
Financial Results/Dividend |
THEMISMED |
N/A |
INE083B01016 |
Themis Medicare Limited |
03 May 2024, 16:27:42 |
Financial Results |
THEMISMED |
N/A |
INE083B01016 |
Themis Medicare Limited |
29 Jan 2024, 16:14:10 |
THEMIS MEDICARE LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2023 . |
THEMISMED |
N/A |
INE083B01016 |
Themis Medicare Limited |
25 Oct 2023, 12:16:02 |
NSE: THEMISMED Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results |
THEMISMED |
- |
INE083B01016 |
Themis Medicare Limited |
18 Oct 2024, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2024 |
Financial Results |
THEMISMED |
- |
INE083B01016 |
Themis Medicare Limited |
16 Jul 2024, 00:00:00 |
To inter alia, consider and approve the financial results for the period ended June 30, 2024 |
Financial Results/Dividend |
THEMISMED |
- |
INE083B01016 |
Themis Medicare Limited |
03 May 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024 and dividend |
Financial Results |
THEMISMED |
- |
INE083B01016 |
Themis Medicare Limited |
29 Jan 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2023 |
Financial Results |
THEMISMED |
- |
INE083B01016 |
Themis Medicare Limited |
25 Oct 2023, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2023 |
NSE: THEMISMED Balance Sheet Data In (Cr)
| date | period_type | Ordinary Shares Number | Share Issued | Net Debt | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Minority Interest | Stockholders Equity | Other Equity Interest | Fixed Assets Revaluation Reserve | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Non Current Pension And Other Postretirement Benefit Plans | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Debt | Current Liabilities | Other Current Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Current Provisions | Payables | Other Payable | Dividends Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Defined Pension Benefit | Non Current Prepaid Assets | Non Current Deferred Taxes Assets | Investmentin Financial Assets | Held To Maturity Securities | Available For Sale Securities | Financial Assets Designatedas Fair Value Through Profitor Loss | Long Term Equity Investment | Investmentsin Joint Venturesat Cost | Investments In Other Ventures Under Equity Method | Investmentsin Associatesat Cost | Goodwill And Other Intangible Assets | Other Intangible Assets | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Restricted Cash | Prepaid Assets | Inventory | Finished Goods | Work In Process | Raw Materials | Other Receivables | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 92,040,120.00 | 92,040,120.00 | 717,543,000.00 | 814,538,000.00 | 4,115,724,000.00 | 4,934,690,000.00 | 1,536,798,000.00 | 4,115,724,000.00 | 0.00 | 4,120,152,000.00 | 4,359,081,000.00 | 4,120,139,000.00 | -13,000.00 | 4,120,152,000.00 | 4,028,112,000.00 | 0.00 | 0.00 | 0.00 | 92,040,000.00 | 92,040,000.00 | 1,902,005,000.00 | 317,857,000.00 | 0.00 | 78,928,000.00 | 238,929,000.00 | 0.00 | 238,929,000.00 | 1,584,148,000.00 | 8,603,000.00 | 575,609,000.00 | 0.00 | 575,609,000.00 | 0.00 | 24,448,000.00 | 683,053,000.00 | 0.00 | 0.00 | 153,200,000.00 | 529,853,000.00 | 6,022,144,000.00 | 2,901,198,000.00 | 127,611,000.00 | 0.00 | 0.00 | 0.00 | 14,135,000.00 | 0.00 | 14,135,000.00 | 0.00 | 989,290,000.00 | 0.00 | 0.00 | 0.00 | 4,428,000.00 | 0.00 | 1,765,734,000.00 | 0.00 | 1,765,734,000.00 | 32,441,000.00 | 1,733,293,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,120,946,000.00 | 236,525,000.00 | 0.00 | 0.00 | 645,538,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,006,609,000.00 | 0.00 | 0.00 | 232,274,000.00 | 135,279,000.00 | 96,995,000.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 92,040,120.00 | 92,040,120.00 | 837,886,000.00 | 957,922,000.00 | 3,771,146,000.00 | 4,713,769,000.00 | 1,385,834,000.00 | 3,771,146,000.00 | 20,819,000.00 | 3,776,666,000.00 | 4,027,997,000.00 | 3,776,654,000.00 | -12,000.00 | 3,776,666,000.00 | 3,684,626,000.00 | 333,714,000.00 | 2,319,349,000.00 | 355,659,000.00 | 92,040,000.00 | 92,040,000.00 | 1,887,511,000.00 | 341,665,000.00 | 0.00 | 73,925,000.00 | 267,740,000.00 | 16,409,000.00 | 251,331,000.00 | 1,545,846,000.00 | 42,973,000.00 | 690,182,000.00 | 4,410,000.00 | 685,772,000.00 | 25,645,000.00 | 25,645,000.00 | 787,046,000.00 | 229,856,000.00 | 1,293,000.00 | 82,974,000.00 | 472,923,000.00 | 5,664,165,000.00 | 2,732,485,000.00 | 124,646,000.00 | 0.00 | 0.00 | 0.00 | 13,050,000.00 | 0.00 | 9,373,000.00 | 3,677,000.00 | 885,116,000.00 | 371,808,000.00 | 0.00 | 513,308,000.00 | 5,520,000.00 | 5,520,000.00 | 1,704,153,000.00 | -691,713,000.00 | 2,395,866,000.00 | 26,018,000.00 | 54,741,000.00 | 1,458,943,000.00 | 240,820,000.00 | 615,344,000.00 | 0.00 | 2,931,680,000.00 | 10,521,000.00 | 93,744,000.00 | 241,339,000.00 | 705,743,000.00 | 324,836,000.00 | 133,508,000.00 | 247,399,000.00 | 1,661,000.00 | 1,779,455,000.00 | 0.00 | 0.00 | 99,217,000.00 | 144,798,000.00 | 99,217,000.00 | 99,217,000.00 |
| 2024-03-31T00:00:00 | annual | 92,040,120.00 | 92,040,120.00 | 837,886,000.00 | 957,922,000.00 | 3,771,146,000.00 | 4,713,769,000.00 | 1,385,834,000.00 | 3,771,146,000.00 | 20,819,000.00 | 3,776,666,000.00 | 4,027,997,000.00 | 3,776,654,000.00 | -12,000.00 | 3,776,666,000.00 | 3,684,626,000.00 | 333,714,000.00 | 2,319,349,000.00 | 355,659,000.00 | 92,040,000.00 | 92,040,000.00 | 1,887,511,000.00 | 341,665,000.00 | 0.00 | 73,925,000.00 | 267,740,000.00 | 16,409,000.00 | 251,331,000.00 | 1,545,846,000.00 | 42,973,000.00 | 690,182,000.00 | 4,410,000.00 | 685,772,000.00 | 25,645,000.00 | 25,645,000.00 | 787,046,000.00 | 229,856,000.00 | 1,293,000.00 | 82,974,000.00 | 472,923,000.00 | 5,664,165,000.00 | 2,732,485,000.00 | 124,646,000.00 | 0.00 | 0.00 | 0.00 | 13,050,000.00 | 0.00 | 9,373,000.00 | 3,677,000.00 | 885,116,000.00 | 371,808,000.00 | 0.00 | 513,308,000.00 | 5,520,000.00 | 5,520,000.00 | 1,704,153,000.00 | -691,713,000.00 | 2,395,866,000.00 | 26,018,000.00 | 54,741,000.00 | 1,458,943,000.00 | 240,820,000.00 | 615,344,000.00 | 0.00 | 2,931,680,000.00 | 10,521,000.00 | 93,744,000.00 | 241,339,000.00 | 705,743,000.00 | 324,836,000.00 | 133,508,000.00 | 247,399,000.00 | 1,661,000.00 | 1,779,455,000.00 | 0.00 | 0.00 | 99,217,000.00 | 144,798,000.00 | 99,217,000.00 | 99,217,000.00 |
| 2023-09-30T00:00:00 | quarterly | 92,027,700.00 | 92,027,700.00 | 811,077,000.00 | 945,871,000.00 | 3,634,818,000.00 | 4,587,301,000.00 | 1,358,741,000.00 | 3,634,818,000.00 | 0.00 | 3,641,430,000.00 | 3,921,113,000.00 | 3,641,421,000.00 | -9,000.00 | 3,641,430,000.00 | 3,549,402,000.00 | 0.00 | 0.00 | 0.00 | 92,028,000.00 | 92,028,000.00 | 1,843,290,000.00 | 350,993,000.00 | 0.00 | 71,310,000.00 | 279,683,000.00 | 0.00 | 279,683,000.00 | 1,492,297,000.00 | 10,920,000.00 | 666,188,000.00 | 0.00 | 666,188,000.00 | 0.00 | 29,161,000.00 | 506,055,000.00 | 0.00 | 0.00 | 88,437,000.00 | 417,618,000.00 | 5,484,711,000.00 | 2,633,673,000.00 | 135,621,000.00 | 0.00 | 0.00 | 0.00 | 11,929,000.00 | 0.00 | 11,929,000.00 | 0.00 | 795,857,000.00 | 0.00 | 795,857,000.00 | 0.00 | 6,612,000.00 | 0.00 | 1,683,654,000.00 | 0.00 | 1,683,654,000.00 | 32,911,000.00 | 1,650,743,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,851,038,000.00 | 203,151,000.00 | 0.00 | 0.00 | 596,365,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,775,671,000.00 | 0.00 | 0.00 | 275,851,000.00 | 141,057,000.00 | 134,794,000.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 92,027,700.00 | 92,027,700.00 | 773,063,000.00 | 923,752,000.00 | 3,386,719,000.00 | 4,292,951,000.00 | 1,254,014,000.00 | 3,386,719,000.00 | 25,224,000.00 | 3,394,423,000.00 | 3,661,403,000.00 | 3,394,414,000.00 | -9,000.00 | 3,394,423,000.00 | 650,000.00 | 337,716,000.00 | 1,932,941,000.00 | 355,256,000.00 | 92,028,000.00 | 92,028,000.00 | 1,745,147,000.00 | 353,862,000.00 | 0.00 | 69,407,000.00 | 284,455,000.00 | 17,475,000.00 | 266,980,000.00 | 1,391,285,000.00 | 44,349,000.00 | 639,297,000.00 | 7,749,000.00 | 631,548,000.00 | 23,919,000.00 | 23,919,000.00 | 683,720,000.00 | 200,798,000.00 | 975,000.00 | 81,500,000.00 | 400,447,000.00 | 5,139,561,000.00 | 2,494,262,000.00 | 142,568,000.00 | 14,484,000.00 | 128,084,000.00 | 0.00 | 6,500,000.00 | 0.00 | 3,724,000.00 | 2,776,000.00 | 697,162,000.00 | 305,245,000.00 | 697,162,000.00 | 391,917,000.00 | 7,704,000.00 | 7,704,000.00 | 1,640,328,000.00 | -572,871,000.00 | 2,213,199,000.00 | 26,001,000.00 | 52,557,000.00 | 1,293,855,000.00 | 225,442,000.00 | 615,344,000.00 | 0.00 | 2,645,299,000.00 | 10,522,000.00 | 63,390,000.00 | 304,501,000.00 | 689,520,000.00 | 318,500,000.00 | 124,140,000.00 | 246,880,000.00 | 1,661,000.00 | 1,450,240,000.00 | 0.00 | 1,450,240,000.00 | 125,465,000.00 | 112,623,000.00 | 125,465,000.00 | 125,465,000.00 |
| 2023-03-31T00:00:00 | annual | 92,027,700.00 | 92,027,700.00 | 773,063,000.00 | 923,752,000.00 | 3,386,719,000.00 | 4,292,951,000.00 | 1,254,014,000.00 | 3,386,719,000.00 | 25,224,000.00 | 3,394,423,000.00 | 3,661,403,000.00 | 3,394,414,000.00 | -9,000.00 | 3,394,423,000.00 | 650,000.00 | 337,716,000.00 | 1,932,941,000.00 | 355,256,000.00 | 92,028,000.00 | 92,028,000.00 | 1,745,147,000.00 | 353,862,000.00 | 0.00 | 69,407,000.00 | 284,455,000.00 | 17,475,000.00 | 266,980,000.00 | 1,391,285,000.00 | 44,349,000.00 | 639,297,000.00 | 7,749,000.00 | 631,548,000.00 | 23,919,000.00 | 23,919,000.00 | 683,720,000.00 | 200,798,000.00 | 975,000.00 | 81,500,000.00 | 400,447,000.00 | 5,139,561,000.00 | 2,494,262,000.00 | 142,568,000.00 | 14,484,000.00 | 128,084,000.00 | 0.00 | 6,500,000.00 | 0.00 | 3,724,000.00 | 2,776,000.00 | 697,162,000.00 | 305,245,000.00 | 697,162,000.00 | 391,917,000.00 | 7,704,000.00 | 7,704,000.00 | 1,640,328,000.00 | -572,871,000.00 | 2,213,199,000.00 | 26,001,000.00 | 52,557,000.00 | 1,293,855,000.00 | 225,442,000.00 | 615,344,000.00 | 0.00 | 2,645,299,000.00 | 10,522,000.00 | 63,390,000.00 | 304,501,000.00 | 689,520,000.00 | 318,500,000.00 | 124,140,000.00 | 246,880,000.00 | 1,661,000.00 | 1,450,240,000.00 | 0.00 | 1,450,240,000.00 | 125,465,000.00 | 112,623,000.00 | 125,465,000.00 | 125,465,000.00 |
| 2022-03-31T00:00:00 | annual | 92,002,700.00 | 92,002,700.00 | 563,880,000.00 | 797,324,000.00 | 2,865,003,000.00 | 3,641,564,000.00 | 1,046,374,000.00 | 2,865,003,000.00 | 30,651,000.00 | 2,874,891,000.00 | 3,097,960,000.00 | 2,874,884,000.00 | -7,000.00 | 2,874,891,000.00 | 2,373,000.00 | 341,718,000.00 | 1,408,403,000.00 | 354,444,000.00 | 92,003,000.00 | 92,003,000.00 | 1,402,921,000.00 | 307,735,000.00 | 0.00 | 64,724,000.00 | 243,011,000.00 | 19,942,000.00 | 223,069,000.00 | 1,095,186,000.00 | 40,349,000.00 | 554,313,000.00 | 10,709,000.00 | 543,604,000.00 | 18,604,000.00 | 18,604,000.00 | 481,920,000.00 | 123,582,000.00 | 4,991,000.00 | 34,609,000.00 | 318,738,000.00 | 4,277,805,000.00 | 2,136,245,000.00 | 89,314,000.00 | 20,278,000.00 | 69,036,000.00 | 0.00 | 20,463,000.00 | 58,000.00 | 18,216,000.00 | 2,247,000.00 | 560,839,000.00 | 275,185,000.00 | 0.00 | 285,654,000.00 | 9,888,000.00 | 9,888,000.00 | 1,455,741,000.00 | -470,500,000.00 | 1,926,241,000.00 | 25,618,000.00 | 51,317,000.00 | 1,037,841,000.00 | 196,121,000.00 | 615,344,000.00 | 0.00 | 2,141,560,000.00 | 10,464,000.00 | 62,200,000.00 | 244,710,000.00 | 608,094,000.00 | 215,497,000.00 | 149,194,000.00 | 243,403,000.00 | 7,671,000.00 | 1,005,628,000.00 | 0.00 | 1,005,628,000.00 | 202,793,000.00 | 111,616,000.00 | 202,793,000.00 | 202,793,000.00 |
| 2021-03-31T00:00:00 | annual | 91,884,540.00 | 91,884,540.00 | 651,410,000.00 | 871,820,000.00 | 2,172,996,000.00 | 3,026,658,000.00 | 571,634,000.00 | 2,172,996,000.00 | 30,230,000.00 | 2,185,068,000.00 | 2,398,746,000.00 | 2,185,062,000.00 | -6,000.00 | 2,185,068,000.00 | 3,655,000.00 | 345,720,000.00 | 717,241,000.00 | 350,607,000.00 | 91,885,000.00 | 91,885,000.00 | 1,526,339,000.00 | 243,278,000.00 | 0.00 | 9,483,000.00 | 233,795,000.00 | 20,117,000.00 | 213,678,000.00 | 1,283,061,000.00 | 41,849,000.00 | 638,025,000.00 | 10,113,000.00 | 627,912,000.00 | 14,930,000.00 | 14,930,000.00 | 493,951,000.00 | 180,470,000.00 | 1,604,000.00 | 3,958,000.00 | 307,919,000.00 | 3,711,401,000.00 | 1,856,706,000.00 | -54,000.00 | 20,278,000.00 | 28,299,000.00 | 0.00 | 4,778,000.00 | 58,000.00 | 2,871,000.00 | 1,907,000.00 | 447,621,000.00 | 239,383,000.00 | 0.00 | 208,238,000.00 | 12,072,000.00 | 12,072,000.00 | 1,343,712,000.00 | -380,468,000.00 | 1,724,180,000.00 | 24,721,000.00 | 50,095,000.00 | 848,343,000.00 | 185,677,000.00 | 615,344,000.00 | 0.00 | 1,854,695,000.00 | 10,946,000.00 | 56,155,000.00 | 228,705,000.00 | 584,944,000.00 | 260,314,000.00 | 134,989,000.00 | 189,641,000.00 | 7,671,000.00 | 776,094,000.00 | 0.00 | 0.00 | 190,180,000.00 | 109,352,000.00 | 190,180,000.00 | 190,180,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 29,069,000.00 | 45,724,000.00 | 0.00 | 58,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: THEMISMED Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Repayment Of Debt | Issuance Of Debt | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Other Cash Adjustment Outside Changein Cash | Beginning Cash Position | Changes In Cash | Financing Cash Flow | Net Other Financing Charges | Interest Paid Cff | Cash Dividends Paid | Net Common Stock Issuance | Common Stock Issuance | Net Issuance Payments Of Debt | Net Short Term Debt Issuance | Short Term Debt Payments | Short Term Debt Issuance | Net Long Term Debt Issuance | Long Term Debt Issuance | Investing Cash Flow | Net Other Investing Changes | Interest Received Cfi | Dividends Received Cfi | Net Investment Purchase And Sale | Purchase Of Investment | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Other Current Liabilities | Change In Other Current Assets | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Provisionand Write Offof Assets | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Gain Loss On Investment Securities | Net Foreign Currency Exchange Gain Loss | Gain Loss On Sale Of PPE | Gain Loss On Sale Of Business | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 36,757,000.00 | 0.00 | 0.00 | 415,000.00 | -184,179,000.00 | 99,217,000.00 | 0.00 | 125,465,000.00 | -26,248,000.00 | -87,704,000.00 | 0.00 | -76,275,000.00 | -46,014,000.00 | 415,000.00 | 415,000.00 | 38,361,000.00 | 55,076,000.00 | 0.00 | 0.00 | -16,715,000.00 | 0.00 | -159,480,000.00 | 0.00 | 8,393,000.00 | 16,057,000.00 | 0.00 | 0.00 | -183,930,000.00 | 249,000.00 | -184,179,000.00 | 220,936,000.00 | -89,562,000.00 | -209,163,000.00 | 30,274,000.00 | 27,160,000.00 | 72,476,000.00 | -16,223,000.00 | -329,215,000.00 | 76,275,000.00 | 0.00 | 122,463,000.00 | 2,184,000.00 | 120,279,000.00 | -25,353,000.00 | 72,000.00 | -174,000.00 | 0.00 | 534,432,000.00 |
| 2023-03-31T00:00:00 | annual | -126,554,000.00 | 0.00 | 0.00 | 837,000.00 | -287,479,000.00 | 125,465,000.00 | 0.00 | 202,793,000.00 | -77,328,000.00 | 1,362,000.00 | 0.00 | -79,902,000.00 | -46,001,000.00 | 837,000.00 | 837,000.00 | 134,063,000.00 | 88,428,000.00 | 0.00 | 0.00 | 45,635,000.00 | 0.00 | -239,615,000.00 | 0.00 | 5,473,000.00 | 42,051,000.00 | 0.00 | 0.00 | -287,139,000.00 | 340,000.00 | -287,479,000.00 | 160,925,000.00 | -161,548,000.00 | -402,961,000.00 | 76,591,000.00 | -40,538,000.00 | 81,709,000.00 | -81,426,000.00 | -444,612,000.00 | 79,902,000.00 | 0.00 | 104,948,000.00 | 2,184,000.00 | 102,764,000.00 | -48,053,000.00 | -117,000.00 | -212,000.00 | 1,000.00 | 725,149,000.00 |
| 2022-03-31T00:00:00 | annual | 137,668,000.00 | 0.00 | 0.00 | 3,955,000.00 | -206,273,000.00 | 202,793,000.00 | 0.00 | 190,180,000.00 | 12,613,000.00 | -175,469,000.00 | 0.00 | -65,369,000.00 | -39,558,000.00 | 3,955,000.00 | 3,955,000.00 | -66,066,000.00 | -82,917,000.00 | 0.00 | 0.00 | 16,851,000.00 | 0.00 | -155,859,000.00 | 0.00 | 6,055,000.00 | 31,133,000.00 | 0.00 | 0.00 | -193,047,000.00 | 13,226,000.00 | -206,273,000.00 | 343,941,000.00 | -180,737,000.00 | -425,529,000.00 | -146,160,000.00 | -36,915,000.00 | 10,815,000.00 | -23,150,000.00 | -229,534,000.00 | 65,369,000.00 | 0.00 | 94,798,000.00 | 2,184,000.00 | 92,614,000.00 | -37,527,000.00 | 0.00 | -11,650,000.00 | 0.00 | 952,620,000.00 |
| 2021-03-31T00:00:00 | annual | 389,363,000.00 | -196,855,000.00 | 72,569,000.00 | 155,000.00 | -180,388,000.00 | 190,180,000.00 | 0.00 | 33,415,000.00 | 156,765,000.00 | -256,474,000.00 | 1,000.00 | -109,657,000.00 | -16,079,000.00 | 155,000.00 | 155,000.00 | -124,287,000.00 | -136,539,000.00 | -196,855,000.00 | 0.00 | 12,252,000.00 | 72,569,000.00 | -156,512,000.00 | 0.00 | 4,121,000.00 | 19,280,000.00 | 0.00 | 0.00 | -179,913,000.00 | 475,000.00 | -180,388,000.00 | 569,751,000.00 | 770,000.00 | 79,036,000.00 | -36,244,000.00 | -102,650,000.00 | 11,088,000.00 | -38,855,000.00 | 248,749,000.00 | 109,657,000.00 | 0.00 | 85,471,000.00 | 2,184,000.00 | 83,287,000.00 | -23,589,000.00 | 0.00 | -226,000.00 | 0.00 | 413,307,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 175,608,000.00 | 0.00 | 0.00 | 0.00 | -1,000.00 | 0.00 | 0.00 | 0.00 | 1,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 97,582,000.00 | 0.00 | 78,026,000.00 | 0.00 | 1,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -8,837,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: THEMISMED Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Average Dilution Earnings | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Minority Interests | Net Income Including Noncontrolling Interests | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Amortization | Depreciation Income Statement | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 0.02 | 0.00 | 73.23 | 0.09 | 0.09 | 43.52 | 12.25 | 139.76 | 73.32 | 61.07 | -8.54 | 7.63 | 0.84 | 43.45 | 43.52 | 337.37 | 2.17 | 9.22 | 9.20 | 0.00 | 0.00 | 43.52 | 0.00 | 43.52 | 0.00 | 43.52 | 0.00 | 43.52 | 43.52 | 9.92 | 53.44 | 0.55 | 0.00 | -8.54 | 1.75 | 7.63 | 0.84 | 39.26 | 197.61 | 72.66 | 12.25 | 0.22 | 12.03 | 33.26 | 22.36 | 10.90 | 2.17 | 236.87 | 139.76 | 376.63 | 376.63 |
| 2023-03-31T00:00:00 | annual | 0.01 | 0.00 | 90.95 | 0.05 | 0.05 | 56.90 | 10.49 | 121.00 | 91.00 | 80.51 | -9.02 | 7.99 | 0.55 | 56.86 | 56.90 | 287.50 | 1.81 | 9.22 | 9.20 | 0.00 | 0.00 | 56.90 | 0.00 | 56.90 | 0.00 | 56.90 | 0.00 | 56.90 | 56.90 | 15.61 | 72.51 | 3.47 | 0.00 | -9.02 | 1.57 | 7.99 | 0.55 | 56.96 | 166.50 | 71.55 | 10.49 | 0.22 | 10.28 | 26.37 | 17.03 | 9.34 | 1.81 | 223.46 | 121.00 | 344.46 | 344.46 |
| 2022-03-31T00:00:00 | annual | 0.01 | 0.00 | 111.24 | 0.03 | 0.03 | 72.88 | 9.48 | 151.99 | 111.28 | 101.80 | -8.17 | 6.54 | 0.61 | 72.85 | 72.88 | 305.19 | 0.98 | 9.22 | 9.20 | 0.00 | 0.00 | 72.88 | 0.00 | 72.88 | 0.00 | 72.88 | 0.00 | 72.88 | 72.88 | 22.38 | 95.26 | 1.26 | 0.00 | -8.17 | 2.24 | 6.54 | 0.61 | 86.16 | 153.20 | 66.18 | 9.48 | 0.22 | 9.26 | 27.85 | 17.93 | 9.92 | 0.98 | 239.35 | 151.99 | 391.35 | 391.35 |
| 2021-03-31T00:00:00 | annual | 0.00 | 0.00 | 60.82 | 0.02 | 0.02 | 35.70 | 8.55 | 80.53 | 60.84 | 52.30 | -12.30 | 10.97 | 0.41 | 35.69 | 35.70 | 188.39 | 0.83 | 9.19 | 9.19 | 0.00 | 0.00 | 35.70 | 0.00 | 35.70 | 0.00 | 35.70 | 0.00 | 35.70 | 35.70 | 5.63 | 41.33 | 0.68 | 0.00 | -12.30 | 1.75 | 10.97 | 0.41 | 40.95 | 107.85 | 43.66 | 8.55 | 0.22 | 8.33 | 16.16 | 9.47 | 6.69 | 0.83 | 148.80 | 80.53 | 229.33 | 229.33 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
5.75
P/E
46.226086
P/B
5.9489703
Dividend Yield
0.19%
Market Cap
2,446.43 Cr.
Face Value
44.68
Book Value
44.68
ROE
12.61%
EBITDA Growth
63.21 Cr.
Debt/Equity
19.77
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of themismed?
The market capitalization of Themis Medicare Limited is ₹2,446 Cr as of 05 Feb 2025.
What are the PE and PB ratios of Themis Medicare Limited?
The PE and PB ratios of Themis Medicare Limited are Not Available and 5.9489703 respectively as of 05 Feb 2025.
What is the 52 Week High of Themis Medicare Limited?
The 52-week high of Themis Medicare Limited is ₹317 as of 05 Feb 2025.
What is the 52 Week Low of Themis Medicare Limited?
The 52-week low of Themis Medicare Limited is ₹180.55 as of 05 Feb 2025.
What are the earnings per share (EPS) for Themis Medicare Limited?
The Earnings Per Share (EPS) of Themis Medicare Limited is ₹5.75 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of Themis Medicare Limited?
The Return on Equity (ROE) of Themis Medicare Limited is 12.61% as per the most recent financial year data. Explore more on Fincept.